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in renal cell cancer
Y. Tomital"2, T. Nishiyama2, M. Fujiwara' & S. Sato2
Department of 'Immunology and 2Urology, Niigata University, School ofMedicine, Asahimachi 1, Niigata 951, Japan.
Summary In order to investigate the anti-tumour immune responsiveness of patients with renal cell cancer
(RCC), we examined 30 such patients for the degree of expression ofmajor histocompatibility complex (MHC)
class I and class II antigens on RCC and the populations of tumour-infiltrating mononuclear cells (TIM).
Normal renal tubular cells expressed class I but not class II antigens. Most of the tumour cells expressed class
I antigens in 25 (83%) cases, but the proportion of such cells was reduced in five cases, three of which were of
granular cell type histologically. Class II antigens were detected in all specimens with class I positivity. Various
numbers of TIM were detected in 25 cases, being composed mainly of T cells and a smaller number of
macrophages. Examination for the phenotype of T cells showed that CD8-positive cells were the dominant
population. B cells were not detected. Quantitative analysis revealed that the numbers of TIM were signi-
ficantly lower in cases showing class I reduction than in those with normal class I expression. Therefore, it was
clear that class I antigens were preserved in RCC cells in most cases. Furthermore, a higher rate of reduction
of class I antigens was observed in cases of granular cell type, which has been reported to have a worse
prognosis than the clear cell type. The present data suggest that degree of the expression of MHC class I
antigen on RCC might influence the host immune responsiveness against it.
Renal cell carcinoma (RCC), which accounts for about 90%
of tumours originating from the renal parenchyma, has char-
acteristics unique among malignant tumours. First, more
than 50 cases of spontaneous regression have been reported
(Freed et al., 1977), an incidence that is remarkably higher
than that seen in other malignant tumours. Second, RCC
shows a relatively high response to adoptive immunotherapy
with lymphokine-activated killer (LAK) cells (Rosenberg et
al., 1987) and also to certain cytokines such as interferon
alpha (Krown et al., 1987). It is also known that tumour-
infiltrating lymphocytes (TIL) obtained from RCC tissue are
able to lyse autologous tumour cells after culture with IL-2
(Belldegrum et al., 1988). In the light of these findings it
seems that the immune system influences the behaviour of
RCC cells in vivo.
Major histocompatibility complex (MHC) class I antigens,
composed of highly polymorphic glycoproteins associated
with beta-2 microglobulin (p2m), are expressed on virtually
all nucleated cells (Daar et al., 1984; Natali et al., 1984).
MHC class I molecules has been shown to act as restriction
elements for the lysis of target cells by cytotoxic T lympho-
cytes (CTL) (Zinkernagel & Doherty, 1979). In a murine
system, it was demonstrated that loss or reduction of class I
molecules on tumour cells decreased their susceptibility to
lysis by CTL (Bernards et al., 1983). Some reports have also
described remarkable reduction of class I antigens in poorly
differentiated tumours (Momburg et al., 1986; Moller et al.,
1987), a highly malignant type of human tumour (van den
Ingh et al., 1987) and also in tumour cell lines (Doyle et al.,
1985). MHC class II molecules are known to function as
restriction molecules for the provision antigen fragments to
helper T cells by antigen-presenting cells (Benacerraf et al.,
1981) and also to be responsible for allograft rejection. Some
kinds of class II-positive tumour cell line are reported to
stimulate proliferation of alloreactive T cells in the mixed
lymphocyte reaction (Fossate et al., 1984; Sakai et al., 1987),
and to induce cytotoxic T cells against class II antigens
(Pfizenmaier et al., 1985). However, in situ studies on class II
antigens of human tumour cells have produced rather confus-
ing results. Some studies have indicated a correlation between
reduction of these antigens and tumour malignancy (Mom-
burg et al., 1987) whereas others have shown that an increase
of the antigens is related to tumour progression (Broker et
al., 1985). Thus, MHC antigens are considered to play an
important role in allowing RCC to escape the host's immune
reaction, so that it seems worthwhile to investigate MHC
class I and II expression and the characterisation of tumour-
infiltrating mononuclear cells (TIM) in RCC. In relation to
this aspect, Natali et al. (1984) detected class I antigens in
nine of ten cases of RCC. On the other hand, Heinemann et
al. (1987) found only two cases of RCC positive for class I
antigen and one positive for class II antigen among 10 cases.
In the present study, we examined the expression of HLA-A,
B, C, P2m and HLA-DR, DQ, DP, and also the population
of TIM using immunoperoxidase staining in a larger number
of cases of RCC.
Materials and methods
Tissue specimens
Specimens were obtained from 30 patients (18 males and 12
females) who had undergone nephrectomy for RCC between
October 1987 and July 1989. None of the patients had
received chemotherapeutic or immunomodulatory agents, or
irradiation preoperatively. Furthermore, there was no evi-
dence of urinary tract infection in these patients. The mean
age at the time of surgery was 59.5 years, with range of
34-78 years. Normal kidney tissues were collected from the
unaffected portion of the removed kidney. All the tissue
samples were embedded in OCT compound (Miles Labora-
tories, Naperville, IL, USA) after being rinsed in PBS, and
then snap-frozen in isopentane precooled in dry ice-acetone.
These blocks were stored at - 80°C until 5 gm frozen sections
were cut in a cryostat.
Histological examinations
Histological examination was performed on haematoxylin
and eosin (H&E)-stained tissue sections. Cancer tissues were
histologically graded according to the General Rule for
Clinical and Pathological Studies on Renal Cell Carcinoma
(Japanese Urological Association, The Japanese Pathological
Society and Japan Radiological Society, 1983). The grading
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system includes low-grade (Gl), moderate-grade (G2) and
high-grade (G3) categories according to the degree of atypia
of the tumour cells. Histological stage was determined
according to the TNM classification of malignant tumours
(UICC, 1987).
Monoclonal antibodies
Monoclonal antibodies used in this study were as follows:
W6/32 (IgG2,) against a monomorphic determinant on the
heavy chain of MHC class I antigens associated with ,2m
(Dako Japan Co., Kyoto, Japan) and SRL-2 (IgG,) against
P2m (Serotec Co., Blackthorn, Bicester, Bucks., UK). For the
detection of class II antigens, L243 (IgG2,) against a mono-
morphic determinant of HLA-DR, SK10 (IgG1) against a
common polymorphic determinant of HLA-DQ, and B7/21
(IgGj) against a monomorphic determinant of HLA-DP were
used. Anti-Leul (IgGu) against pan-T cell (CD5), anti-Leu2a
(IgG,) against cytotoxic/suppressor T cells (CD8), anti-Leu3a
(IgG,) against helper/inducer T cells (CD4), anti-Leul2
(IgG,) against B cells and anti-LeuM3 (IgG2b) against macro-
phages were used for evaluating the TIM phenotypes. These
monoclonal antibodies against class II antigens and immune
cells were purchased from Becton Dickinson, Mountain
View, CA, USA. The optimal dilution of each antibody was
determined by staining two specimens of adenoid vegetation
resected surgically and three specimens of lymph nodes
obtained at nephrectomy for RCC.
Immunoperoxidase staining
Immunoperoxidase staining was performed using the strep-
tavidin-biotin bridge technique (Bonnard et al., 1984). Serial
sections prepared in a cryostat were air-dried for 30 min and
fixed in cold acetone for 10 min. After rehydration with PBS,
the sections were incubated in PBS containing 20% normal
sheep serum (Antibodies Inc., Davis, CA, USA) for 30 min
and endogenous biotin was blocked using an Endogenous
Biotin Blocking Kit (Vector Laboratories, Burlingame, CA,
USA). The sections were then incubated with mouse mono-
clonal antibodies for 60 min followed by incubation with
biotinylated sheep anti-mouse immunoglobulin (Amersham
International, Amersham, Bucks, UK) diluted 1:100, contain-
ing 20% human type AB serum (Biological Speciality Co.,
Lansdale, PA, USA). Subsequently, they were incubated with
streptavidin peroxidase (Amersham) diluted 1:200 for 45 min.
Each step was followed by washing in PBS with three
changes of buffer.
Finally the sections were immersed in 0.05% diaminoben-
zidine (Sigma Chemical Co., St Louis, MO, USA) and 0.01%
HO, in 0.05 M Tris HCI buffer for 3-5 min to visualise the
reaction products. After washing in tap-water, some speci-
mens were counterstained with Mayer's haematoxylin and
mounted with Eukitt (0. Kuldler, Freiburg, FRG) after de-
hydration in a graded ethanol series and xylene. As negative
controls for MHC antigen staining, serial sections of tumour
tissue were stained with the same subclass of monoclonal
antibodies against a variety of immune cells as described
previously. As positive controls for class I antigens, the
staining patterns of endothelial cells, fibroblasts and macro-
phages were checked, and for those of class II antigens
endothelial cells and dendritic cells were examined.
Evaluation ofstaining
After reaction with either anti-class I or II antibodies, the
tumour tissue showed various staining patterns. The degree
of positive staining of tumour cells, which were distinguish-
able from non-tumour cells, was expressed as the approxi-
mate percentage of positive cells. For quantitative analysis of
TIM, five fields were selected randomly and TIM were
counted in serial sections at a magnification of x 100 using a
microscope equipped with a graticule (0.25 mm square,
Olympus, Tokyo). For comparison between the amount of
TIM and clinical and histopathological factors, TIM were
scored according to the sum of anti-Leul- and anti-LeuM3-
positive cells as follows: score 0, none; score 1, occasional
(less than 10 cells per field); score 2, mild (10-49); score 3,
moderate (50-99); score 4, high (more than 100).
Results
Histopathological classification and clinicalfeatures ofRCC
Histopathological classification and clinical features were
examined in each case of RCC and the results are shown in
Table I. Tumour cells were estimated for histological type
and classified into clear cell, granular cell and mixed cell
types. On the basis of the TNM classification, group T2
included 22 cases and group T3a eight cases. The pN cate-
gory consisted of 27 pN0 cases and three pNX cases. There
were five cases with distant metastasis. Pathological examina-
tion of metastatic sites was performed in only two cases, and
three cases had lung lesions which were strongly suspected to
be metastases of RCC on clinical grounds.
Although the follow-up periods after surgery were too
short for evaluation of prognosis, the patients have been
followed from 1 to 22 months, and 26 patients are currently
alive with no evidence of the disease, two are alive with
disease and two have died of other causes.
MHC antigens expression on normal kidney tissue
Before the examination of RCC tissue, we examined the
staining patterns of normal kidney tissue for MHC class I
and II antigens. Class I antigens were expressed on virtually
all cells comprising the renal tubules. The collecting ducts
were stained rather more weakly than glomerular cells and
endothelial cells. Class II antigens were expressed on glome-
rular cells but could not be detected on renal tubular cells in
this study.
Table I Clinical features and histopathological diagnosis of RCC
patients
No.
l
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Sex
F
M
M
M
M
M
M
M
M
F
M
M
F
F
M
M
M
F
M
F
F
M
F
F
M
M
F
F
F
M
Age
58
60
76
62
62
56
34
78
51
65
59
36
38
56
55
70
54
51
58
48
65
53
64
71
60
71
76
53
68
76
TNM
classification
T2N0M0
T2NoMo
T2NoMo
T2NoMo
T2NOMO
T2NoMo
T2NoMo
T2NoMo
T2NoM,
T2NOM0
T2NoMo
T2NoMo
T2NoMo
T2NOMO
T2NOM,
T3NXMI
T2NOM,
T2NoMo
T3NoMo
T3NoMO
T2NoMo
T2NoMo
T3NXMj
T2NoMo
T2NoMo
T3NoMo
T3NoMo
T2NoMo
T3NOMO
T3NoMo
Grade
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Histological
typea
mixed
clear
granular
clear
clear
clear
clear
mixed
clear
ciear
clear
granular
clear
clear
clear
clear
granular
clear
mixed
granular
granular
clear
mixed
granular
clear
clear
clear
clear
mixed
clear
Status"
NED (22)
NED (21)
NED (19)
NED (19)
NED (18)
NED (18)
NED (17)
NED (5)
Alive (14)
NED (13)
NED (13)
NED (13)
NED (12)
NED (11)
NED (10)
Died
Alive (9)
NED (9)
NED (8)
NED (5)
NED (5)
NED (4)
Died
NED (3)
NED (2)
NED (2)
NED (2)
NED (2)
NED (I)
NED (1)
aClear, clear cell type; granular, granular cell type; mixed, mixed cell
type. bNED, no evidence ofdisease; alive, alive with disease; died, died
by other cause. Figures in parentheses were following up months after
operation.356 Y. TOMITA et al.
MHC antigen expression ofRCC
As can be seen in Table II, most of the tumour cells were
positive for class I antigens and P2m, showing greater inten-
sity of staining than the renal tubular cells (Figure 1). In five
cases, reduced expression (less than 30% of cells positive) of
class I antigens was observed (Figure 2). Cases showing
reduced class I antigen expression accounted for 50% cases
in the granular cell group but only 11% of those in the clear
cell group; this difference was significant (X2 = 4.441, Table
III).
Class II antigen expression was more variable than class I
antigen, but surprisingly, class II antigens which could not be
detected on normal renal tubular cells were detected in 28
cases tested for DR antigen staining, 24 for DP and 23 for
DQ. However, the number of class II antigen-positive cells
was lower than that of class I antigen-positive cells except in
one case. Two cases without DR staining were also negative
for DP or DQ. As to the correlation between DP and DQ
expression, an equal number or more DP-positive cells exist-
ed in 25 cases, and more DQ-positive cells existed in the
other five cases. No relationship was found between class II
antigen expression and the clinical or histopathological
features of RCC. In summary, MHC antigens were expressed
on RCC with a hierarchy of positivity of class I antigens,
HLA, DR, DP and DQ.
Infiltrating mononuclear cells in RCC
Various numbers of mononuclear cells had infiltrated the
tumours (Figure 3a-d). These cells were often scattered with-
in the tumours but some remarkable perivascular infiltration
was also seen. The degree of infiltration was evaluated quan-
titatively as described in Materials and methods. These
infiltrating cells were composed of T cells and a smaller
number of macrophages, but B cells were not detected. Upon
phenotyping of the infiltrating T cells, CD8-positive (killer/
suppressor) T cells were predominant in 20 of 23 cases with a
score of more than 2. CD4-positive (helper/inducer) T cells
Figure 1 a, H&E stained clear cell type of RCC (patient 11). b,
Stained with W6/32. Most of the tumour cells are positive.
Bar = 75pM.
were predominant in only three cases. Macrophages were
detected in 17 cases (Figure 3e) but were outnumbered by T
cells. These results are summarised in Table II.
Correlations between MHC antigen expression and the
degree of cellular infiltration were examined for each MHC
antigen. Significant correlation was noticed between class I
antigen reduction and a decrease in the number of infiltrating
cells (P<0.01, x2 = 10.77, Table IV).
Table II Immunohistochemical staining for MHC antigens and tumour infiltrating mononuclear cells
Approximate % ofpositive cells
No. HLA-A,B,C
1 100
2 100
3 100
4 100
5 100
6 30
7 20
8 100
9 100
10 100
11 100
12 5
13 100
14 100
15 100
16 100
17 80
18 100
19 100
20 20
21 90
22 100
23 90
24 25
25 100
26 100
27 100
28 100
29 100
30 100
B2M
100
100
100
100
100
20
20
100
100
100
100
5
100
100
100
100
80
100
100
20
90
100
90
30
100
100
100
100
100
100
DR
50
80
80
100
50
5
10
10
90
80
90
0
90
80
90
90
80
90
60
90
30
90
90
30
100
80
100
100
100
70
DQ
10
60
30
90
10
0
0
10
5
30
10
0
30
30
80
50
10
40
10
5
5
50
70
5
50
30
10
20
30
30
DP
20
80
30
70
10
0
0
10
60
S
20
0
70
50
90
40
20
10
10
5
5
80
90
10
90
30
90
40
60
30
Number ofpositive cells
Leul 2a 3a 12 M3
351 271 152 0 159
248 153 150 0 39
832 528 432 0 0
631 486 172 0 0
36 25 22 0 0
0 0 0 0 0
233 157 143 0 0
332 227 96 0 30
847 570 246 0 60
153 135 86 0 42
567 327 132 0 91
0 0 0 0 0
297 137 176 0 105
872 550 196 0 0
355 247 40 0 80
495 270 259 0 0
238 75 101 0 0
28 17 0 0 93
49 43 0 0 42
0 0 0 0 0
0 0 0 0 0
817 243 574 0 164
526 585 96 0 70
0 0 0 0 0
132 106 25 0 83
136 97 29 0 16
238 147 65 0 0
105 77 42 0 55
46 16 10 0 84
0 0 0 0 0
Ratio of
Leu3a/2a
0.56
0.98
0.82
0.35
0.91
0.42
0.43
0.64
0.40
1.28
0.36
0.16
0.96
1.35
2.36
0.16
0.24
0.30
0.44
0.55
0.63
TIM
score"
4
3
4
4
1
0
2
3
4
2
4
0
4
4
3
3
2
2
2
1
0
4
4
0
2
2
2
2
2
0
'These cases divided into fivecategories according to the number ofTIM, asdescribed in Materials and
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Figure 2 a, H&E stained granular cell type of RCC (patient 12).
b, Stained with W6/32. Tumour cells showed severe reduction of
class I antigens. Note the intense staining of endothelial cells of
vessels in the tumour. Bar = 75gxM.
Table III Correlation between class I antigens expression and
histological cell type
Class I antigens expression on tumour
cells
Cell type Normally expresseda Reducedb
Clear cell type 17 (89) 2 (11)
Granular cell type 3 (50) 3 (50)c
Mixed cell type 5 (100) 0 (0)
Figures in parentheses are % in each group. aMore than 90% of
positivecells. bLess then 30% ofpositivecells. CP<0.05 compared with
clear cell group (X2 = 4.441).
Table IV Correlation between class I antigen expression and the
degree of mononuclear cell infiltration
Class I antigens expression on tumour
cells
TIM score Normally expresseda Reducedb
2-4 22 1
P<0.01, x2= 10.77
Oorl 3 4
aMore than 90% of positive cells. bLess than 30% of positive cells.
Discussion
In the present study, we analysed MHC antigen expression of
RCC cells in 30 cases. Class I antigens were detected on most
of the tumour cells in 25 of the 30 cases. Our results were
very similar to those of Natali et al. (1984), who reported
that nine out of ten cases of RCC expressed class I antigens.
In contrast, Heinemann et al. (1987) reported the detection
of MHC class I antigen in only two out of ten cases of RCC.
Although it is not possible to reconcile these different results,
the reason may have been differences in the monoclonal
antibodies or staining procedures used.
It has been shown that CTL need to recognise MHC class
I molecules in order to lyse target cells (Zinkernagel &
Doherty, 1979). In this connection, it is interesting that the
degree of expression of MHC class I antigens is closely
related to tumour growth in vivo (Tanaka et al., 1985) and
susceptibility to lysis by CTL (Bernards et al., 1983). In our
studies on RCC, class I antigens on the tumour cells seemed
to be preserved to a greater extent than in other types of
cancer, which might be advantageous for host's immune
system since CTL lyse tumour cells in a class I-restricted
manner. This might explain the higher rate of spontaneous
regression in cases of RCC. On the other hand, susceptibility
of tumour cells to natural killer cells, which are considered to
be the main effector cells preventing tumour metastasis
(Waner et al., 1982), is decreased in proportion to increased
expression of class I antigens on tumour cells (Piontek et al.,
1985). This fact seems to contradict the susceptibility of RCC
to CTL lysis, although it might contribute to the propor-
tionally greater percentage of metastasis of RCC among all
other carcinomas (Mostofi & Davis, 1984).
Previous reports showed that reduced expression of class I
antigens was inversely correlated with the degree of differ-
entiation in some types of tumour (Momburg et al., 1986;
Moller et al., 1987). Although no relationships with grade
and TNM classification, or with the age and sex of the
patient were found, a lower degree of expression was
observed in the granular cell type than in the clear or the
mixed cell type. This result is intriguing because the granular
cell type has often been reported to have a worse prognosis
than the clear cell type (Murphy & Mostofi, 1965).
Class II antigens, which could not be detected on normal
renal tubular cells in this study, were variably expressed in all
tumour specimens that expressed class I antigens simultan-
eously. In other types of tumour the correlation between
class II antigen expression and malignancy were diverse. B
cell lymphoma shows reduced class II antigen expression in
accordance with dedifferentiation (Momburg et al., 1987)
whereas class II antigen expression increases with disease
progression in malignant melanoma (Brocker et al., 1985). In
the present study, no correlation was found between HLA-
DR, DQ, DP expressions and clinical and histopathological
features, and it was concluded that MHC antigens were
expressed with the hierarchy: class I antigens, HLA-DR, DP,
DQ. This hierarchy was also reported in a study of gastric
carcinoma (Sakai et al., 1987), although its significance was
not clear.
Recently, TIL were demonstrated to have stronger ability
to lyse tumour cells than lymphokine-activated killer cells
(Rosenberg et al., 1986) and they have been used for adop-
tive immunotherapy (Kradin et al., 1989). TIL of RCC have
been examined to ascertain their effect, and they were
reported to have a potential to lyse autologous tumour cells
after culture with interleukin-2 (Belldegrum et al., 1988). It
was also reported that TIM, which were composed of T cells
and macrophages, frequently infiltrated into RCC
(Heinemann et al., 1987). In the present study, lymphocytes
and a smaller number of macrophages were shown to
infiltrate into RCC tissue in various patterns, and it was also
demonstrated that lymphocytes consisting of T cells and
CD8-positive cells were the dominant population in 20 out of
23 cases. In the remaining seven cases, we were unable to
detect more than 10 TIM per field. Interestingly, in four of
these seven cases with a smaller number of TIM, the tumours
showed reduced expression of class I antigens and the
numbers of TIM were significantly lower in all cases with
class I reduction than in those showing normal class I expres-
sion. These results suggest that the expression of MHC class
I antigen on RCC might influence lymphocyte infiltration
into the tumour.
In this study, class I antigens were found on most of the
RCC cells in 25 out of 30 cases, and the intensity of expres-
sion was comparable with that seen in renal tubular cells.
These results indicate that class I antigen expression is more
preserved in RCC cells compared with other types of cancer.
This would seem advantageous for the host's immune system
against the tumour cells, since CTL are known to lyse class
I-positive tumour cells, and this might be related to the
higher rate of spontaneous regression in cases of RCC (Freed
et al., 1977). Furthermore, the greater degree of reduction of358 Y. TOMITA et al.
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Figure 3 Immunoperoxidase staining for TIM in RCC. a, H&E stained clear cell type of RCC (patient 16). b, Stained with
anti-Leul1 (CD5). Positive cells infiltrated perivascular area and are scattered within the tumour mass. Stained with anti-Leu2a
(CD8) c, and anti-Leu3a (CD4) d, on serial section. e, Stained with anti-LeuM3 for patient 13. Macrophages were scattered within
the tumour mass. Bar =75 iM.
class I antigen expression in the granular cell type, which is
reported to have a worse prognosis than the clear cell type
(Murphy et al., 1965), is intriguing. TIM were significantly
fewer in cases showing class I reduction than in those with
normal class I expression. Since our studies on TIM sub-
populations showed that CD8-positive T cells predominantly
infiltrated in most cases, the degree of expression of MHC
class I antigen on cancer cells is considered to influence the
host immune responsiveness against RCC.
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